SEI Investments’s Acura Pharmaceuticals ACUR Stock Holding History

SEI Investments’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-130	Closed	–	–	3471
2017 Q1	$0	Hold	130	–	–	﹤0.01%	3223
2016 Q4	$0	Hold	130	–	–	﹤0.01%	3163
2016 Q3	$0	Hold	130	–	–	﹤0.01%	3082
2016 Q2	$0	Buy	+130	New	+$335	﹤0.01%	2848

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

SEI Investments's ACUR Position: Q2 2017 in Review

SEI Investments sold out of Acura Pharmaceuticals (ACUR) in Q2 2017, closing a stake of 130 shares.

SEI Investments first reported a position in ACUR in Q2 2016 and held it in 4 quarters. The position peaked at $0 in Q1 2017. 1 fund tracked by Wall St. Rank holds ACUR as of Q2 2017.

SEI Investments reported no remaining Acura Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
SEI Investments sold 130 Acura Pharmaceuticals shares in Q2 2017.
SEI Investments first reported a position in Acura Pharmaceuticals in Q2 2016 and held it in 4 quarters.
SEI Investments's Acura Pharmaceuticals position peaked at $0 in Q1 2017.
1 fund tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2017.

Based on SEI Investments's 13F filing for Q2 2017, filed 31 Jul 2017.